Simultaneous LC-MS/MS analysis of the biomarkers cAMP and cGMP in plasma, CSF and brain tissue

Journal of Neuroscience Methods

Volumn 203, Issue 2, 2012, Pages 338-343

  Oeckl, Patrick ^a   Ferger, Boris ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

CAMP; CGMP; CSF; LC MS MS; Plasma; Rolipram

Indexed keywords

BIOLOGICAL MARKER; CYCLIC AMP; CYCLIC GMP; ROLIPRAM; ZAPRINAST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TISSUE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG PENETRATION; ELECTROSPRAY; IN VIVO STUDY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; CHROMATOGRAPHY, LIQUID; CYCLIC AMP; CYCLIC GMP; MALE; MICE; MICE, INBRED C57BL; PHOSPHODIESTERASE INHIBITORS; TANDEM MASS SPECTROMETRY;

EID: 82055185503     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2011.09.032     Document Type: Article

References (24)

1. Beavo J.A., Brunton L.L. Cyclic nucleotide research - still expanding after half a century. Nat Rev Mol Cell Biol 2002, 3:710-718.
2. Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001, 69:89-95.
3. Cheng J.B., Watson J.W., Pazoles C.J., Eskra J.D., Griffiths R.J., Cohan V.L., et al. The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy. J Pharmacol Exp Ther 1997, 280:621-626.
4. Conti M., Beavo J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 2007, 76:481-511.
5. Cordell R.L., Hill S.J., Ortori C.A., Barrett D.A. Quantitative profiling of nucleotides and related phosphate-containing metabolites in cultured mammalian cells by liquid chromatography tandem electrospray mass spectrometry. J Chromatogr B: Analyt Technol Biomed Life Sci 2008, 871:115-124.
6. Diaz Enrich M.J., Villamarin J.A., Ramos Martinez J.I., Ibarguren I. Measurement of adenosine 3',5'-cyclic monophosphate and guanosine 3', 5'-cyclic monophosphate in mussel (Mytilus galloprovincialis lmk.) by high-performance liquid chromatography with diode array detection. Anal Biochem 2000, 285:105-112.
7. Giorgi M., Dàngelo V., Esposito Z., Nuccetelli V., Sorge R., Martorana A., et al. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms. Eur J Neurosci 2008, 28:941-950.
8. Goossens J.F., Leroux F., Pommery N., Pommery J., Henichart J.P. High-performance liquid chromatographic determination of cyclic 3',5'-AMP with fluorescence detection. Vasoactive intestinal peptide-induced modification of its concentration in neuroblastoma cells. J Chromatogr B: Biomed Appl 1994, 657:192-196.
9. Goutier W., Spaans P.A., van der Neut M.A., McCreary A.C., Reinders J.H. Development and application of an LC-MS/MS method for measuring the effect of (partial) agonists on cAMP accumulation in vitro. J Neurosci Methods 2010, 188:24-31.
10. Ibrahim M.A., Asai H., Satoh S., Satoh N., Ueda S. Effect of zaprinast on nitric oxide levels in serum and aortic tissue. Methods Find Exp Clin Pharmacol 2004, 26:19-24.
11. Lorenzetti R., Lilla S., Donato J.L., de N.G. Simultaneous quantification of GMP, AMP, cyclic GMP and cyclic AMP by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B: Analyt Technol Biomed Life Sci 2007, 859:37-41.
12. Marte A., Pepicelli O., Cavallero A., Raiteri M., Fedele E. In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats. J Neurosci Res 2008, 86:3338-3347.
13. Martens-Lobenhoffer J., Dautz C., Bode-Boger S.M. Improved method for the determination of cyclic guanosine monophosphate (cGMP) in human plasma by LC-MS/MS. J Chromatogr B: Analyt Technol Biomed Life Sci 2010, 878:487-491.
14. Reffelmann T., Kloner R.A. Phosphodiesterase 5 inhibitors: are they cardioprotective?. Cardiovasc Res 2009, 83:204-212.
15. Rehmann H., Wittinghofer A., Bos J.L. Capturing cyclic nucleotides in action: snapshots from crystallographic studies. Nat Rev Mol Cell Biol 2007, 8:63-73.
16. Reneerkens O.A., Rutten K., Steinbusch H.W., Blokland A., Prickaerts J. Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. Psychopharmacology (Berl) 2009, 202:419-443.
17. Rodrigo R., Monfort P., Cauli O., Erceg S., Felipo V. Pharmacological manipulation of cyclic GMP levels in brain restores learning ability in animal models of hepatic encephalopathy: therapeutic implications. Neuropsychiatr Dis Treat 2006, 2:53-63.
18. Savai R., Pullamsetti S.S., Banat G.A., Weissmann N., Ghofrani H.A., Grimminger F., et al. Targeting cancer with phosphodiesterase inhibitors. Expert Opin Investig Drugs 2010, 19:117-131.
19. Torremans A., Ahnaou A., Van H.A., Straetemans R., Geys H., Vanhoof G., et al. Effects of phosphodiesterase 10 inhibition on striatal cyclic AMP and peripheral physiology in rats. Acta Neurobiol Exp (Wars) 2010, 70:13-19.
20. Torremans A., Van H.A., Straetemans R., Vanhoof G., Van Den K.G., Drinkenburg W.H. Selective D1 agonism but not D2 antagonism is reflected in cAMP and cGMP levels in rat CSF. Brain Res Bull 2010, 81:549-551.
21. Wade M.R., Tzavara E.T., Nomikos G.G. Cannabinoids reduce cAMP levels in the striatum of freely moving rats: an in vivo microdialysis study. Brain Res 2004, 1005:117-123.
22. Witters E., Van D.W., Esmans E.L., Van Onckelen H.A. Ion-pair liquid chromatography-electrospray mass spectrometry for the analysis of cyclic nucleotides. J Chromatogr B: Biomed Sci Appl 1997, 694:55-63.
23. Zaccolo M., Movsesian M.A. cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology. Circ Res 2007, 100:1569-1578.
24. Zhang Y., Dufield D., Klover J., Li W., Szekely-Klepser G., Lepsy C., et al. Development and validation of an LC-MS/MS method for quantification of cyclic guanosine 3',5'-monophosphate (cGMP) in clinical applications: a comparison with a EIA method. J Chromatogr B: Analyt Technol Biomed Life Sci 2009, 877:513-520.